Tayo Adekiya to Animals
This is a "connection" page, showing publications Tayo Adekiya has written about Animals.
Connection Strength
0.340
-
Adekiya TA, Hudson T, Bakare O, Ameyaw EE, Adebayo A, Olajubutu O, Adesina SK. PSMA-targeted combination brusatol and docetaxel nanotherapeutics for the treatment of prostate cancer. Biomed Pharmacother. 2024 Aug; 177:117125.
Score: 0.075
-
Adekiya TA, Kumar P, Kondiah PPD, Ubanako P, Choonara YE. In Vivo Evaluation of Praziquantel-Loaded Solid Lipid Nanoparticles against S. mansoni Infection in Preclinical Murine Models. Int J Mol Sci. 2022 Aug 22; 23(16).
Score: 0.066
-
Adekiya TA, Kumar P, Kondiah PPD, Pillay V, Choonara YE. Synthesis and therapeutic delivery approaches for praziquantel: a patent review (2010-present). Expert Opin Ther Pat. 2021 Sep; 31(9):851-865.
Score: 0.060
-
Adekiya TA, Aruleba RT, Klein A, Fadaka AO. In silico inhibition of SGTP4 as a therapeutic target for the treatment of schistosomiasis. J Biomol Struct Dyn. 2022 05; 40(8):3697-3705.
Score: 0.058
-
Adekiya TA, Aruleba RT, Oyinloye BE, Okosun KO, Kappo AP. The Effect of Climate Change and the Snail-Schistosome Cycle in Transmission and Bio-Control of Schistosomiasis in Sub-Saharan Africa. Int J Environ Res Public Health. 2019 12 26; 17(1).
Score: 0.055
-
Ojo OA, Afon AA, Ojo AB, Ajiboye BO, Okesola MA, Aruleba RT, Adekiya TA, Oyinloye BE. Spondias mombim L. (Anacardiaceae): Chemical fingerprints, inhibitory activities, and molecular docking on key enzymes relevant to erectile dysfunction and Alzheimer's diseases. J Food Biochem. 2019 03; 43(3):e12772.
Score: 0.013
-
Aruleba RT, Adekiya TA, Oyinloye BE, Masamba P, Mbatha LS, Pretorius A, Kappo AP. PZQ Therapy: How Close are we in the Development of Effective Alternative Anti-schistosomal Drugs? Infect Disord Drug Targets. 2019; 19(4):337-349.
Score: 0.013